View Cart  

Restructuring of CDRH’s OC Proposed to Further Foreign Focus: Official

A A
SEATTLE — The FDA is considering the creation of a new Division of International Compliance Operations within CDRH’s Office of Compliance (OC) as part of the center’s efficiency drive and the agency’s increased international focus, CDRH officials say.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00